While CXCL12/CXCR4 activation within both cancer cells and local stroma clearly contributes to GBM cell proliferation, spreading, and survival to therapy, more recent studies demonstrated that CXCR7 is an alternative, or additional, regulator of GBM growth. This evidence concerns the gene CXCR4 and glioblastoma.